4th AMENDMENT OF EXCLUSIVE LICENSE AGREEMENT
4th AMENDMENT OF EXCLUSIVE LICENSE AGREEMENT
This 4th Amendment to the Exclusive License Agreement (hereinafter called “Amendment”), to be effective as of the 24th day of January, 2008, is by and between Protea Biosciences, Inc., a Delaware corporation having its principal place of business at 000 Xxxxxxx Xxx Xxxx #000, Xxxxxxxxxx, XX 00000, (hereinafter referred to as “LICENSEE”) and West Virginia University Research Corporation (hereinafter referred to as “LICENSOR”), a nonprofit West Virginia corporation having its principal place of business at Chestnut Ridge Research Building, 886 Chestnut Ridge Road, XX Xxx 0000, Xxxxxxxxxx, XX 00000-0000, acting for and on behalf of West Virginia University (“WVU”).
WHEREAS, LICENSOR has developed or is developing and owns certain new technologies defined in the Appendix to the Exclusive License Agreement;
WHEREAS, LICENSEE has an exclusive option on the “Subject Technology” (as defined in the Agreement) resulting from an Exclusive Option Agreement signed by the Parties on 12/21/05;
WHEREAS, the Parties have signed an Exclusive License Agreement on the “Subject Technology” and have a desire to update the “Fields of Invention” by adding two fields;
WHEREAS, LICENSOR is willing to grant a new worldwide, exclusive license on the terms set forth herein to the “Subject Technology” to LICENSEE in this Agreement; and
WHEREAS, LICENSEE desires to obtain said worldwide, exclusive, license to the Subject Technology by the newly assigned Principal Investigator;
NOW, THEREFORE, WITNESSETH, that for and in consideration of the mutual promises and agreements herein contained, and other good and valuable consideration, the receipt and sufficiency of all of which are hereby acknowledged, the Parties hereto expressly agree as follows:
1. The following field shall be added to the APPENDIX as APPENDIX V:
APPENDIX V (SUBJECT TECHNOLOGY V);
FIELD OF INVENTION—FUNCTIONALIZED MICROCANTILEVER SENSOR AND ASSOCIATED METHOD FOR DETECTION OF TARGETED ANALYTES; PRINCIPAL INVESTIGATORS Xxxxxx Xxxxx, PhD., Xxxxx Xxxxxxx, Xxxxx Xxxxxxxx, and Xxxxxx Xxxxx.
1
2. The “APPENDIX” shall be amended as if the same had been originally set forth therein as follows.
IN WITNESS WHEREOF, the Parties hereto have executed and delivered this Agreement in multiple originals by their duly authorized officers and representatives on the respective dates shown below, but effective as of the Agreement Date.
|
WEST VIRGINIA UNIVERSITY
|
||
|
RESEARCH CORPORATION, Licensor
|
||
|
Sign:
|
/s/ Xxxxx Xxxxxx | |
|
Dated: Jan. 24, 2008
|
Title:
|
Director of Technology Transfer
|
| Xxxxxxx Xxxxxx | ||
|
Licensee
|
||
|
Sign:
|
/s/ Xxxxxxx Xxxxxx
|
|
|
Dated: 1-24-08
|
Title:
|
CEO
|
2
APPENDIX V (SUBJECT TECHNOLOGY V);
FIELD OF INVENTION—FUNCTIONALIZED MICROCANTILEVER SENSOR
AND ASSOCIATED METHOD FOR DETECTION OF TARGETED ANALYTES;
PRINCIPAL INVESTIGATORS Xxxxxx Xxxxx, PhD., Xxxxx Xxxxxxx, Xxxxx
Xxxxxxxx, and Xxxxxx Xxxxx.
1. Disclosure #319—Detection of Cancer Marker Proteins via functionalized Cantilevers.
2. Disclosure #423—Functionalized Microcantilever Sensor and Associated Method for Detection of Targeted Analytes.
3
